TCM
TMCI icon

TimesSquare Capital Management’s Treace Medical Concepts TMCI Stock Holding History

TimesSquare Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,384,129
Closed -$18.1M – 169
2024
Q1 		$18.1M Sell
1,384,129
-364,991
-21% -$4.87M 0.26% 125
2023
Q4 		$22.3M Buy
1,749,120
+315,691
+22% +$3.19M 0.33% 110
2023
Q3 		$18.8M Buy
1,433,429
+584,539
+69% +$10.7M 0.29% 123
2023
Q2 		$21.7M Sell
848,890
-5,610
-0.7% -$145K 0.31% 124
2023
Q1 		$21.5M Sell
854,500
-121,500
-12% -$2.85M 0.31% 123
2022
Q4 		$22.4M Sell
976,000
-38,500
-4% -$886K 0.32% 124
2022
Q3 		$22.4M Buy
1,014,500
+141,976
+16% +$2.75M 0.31% 132
2022
Q2 		$12.5M Sell
872,524
-800
-0.1% -$13.5K 0.17% 158
2022
Q1 		$16.5M Sell
873,324
-38,756
-4% -$753K 0.19% 160
2021
Q4 		$17M Buy
912,080
+343,100
+60% +$7.08M 0.15% 172
2021
Q3 		$15.3M Buy
+568,980
New +$15.7M 0.13% 191

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TimesSquare Capital Management's TMCI Position: Q2 2024 in Review

TimesSquare Capital Management sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 1,384,129 shares — an estimated $18.1M sold.

TimesSquare Capital Management first reported a position in TMCI in Q3 2021 and held it in 11 quarters. The position peaked at $22.4M in Q4 2022. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • TimesSquare Capital Management reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • TimesSquare Capital Management sold 1,384,129 Treace Medical Concepts shares in Q2 2024, an estimated $18.1M.
  • TimesSquare Capital Management first reported a position in Treace Medical Concepts in Q3 2021 and held it in 11 quarters.
  • TimesSquare Capital Management's Treace Medical Concepts position peaked at $22.4M in Q4 2022.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on TimesSquare Capital Management's 13F filing for Q2 2024, filed 8 Aug 2024.